Chantal Rigal

Centre Hospitalier Régional et Universitaire de Nancy — France

Medicine · Health Sciences

6h-index394citations13works3.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(3), Immunotherapy and Immune Responses(3), Immune Cell Function and Interaction(3), Cancer Cells and Metastasis(2), Cancer, Hypoxia, and Metabolism(2)

Publications11 total

Gestion de la toxicité cutanée induite par les inhibiteurs du récepteur du facteur de croissance épidermique (iEGFR) dans les carcinomes épidermoïdes de la tête et du cou, le cancer colorectal ou le cancer du poumon
Annales de Dermatologie et de Vénéréologie - FMC·2021
Abstract 3112: Prospective immune phenotyping of neuroblastoma children at diagnosis reveals specific immune defects related to the aggressiveness of the disease
Cancer Research·2019
Abstract 3112: Prospective immune phenotyping of neuroblastoma children at diagnosis reveals specific immune defects related to the aggressiveness of the disease
Clinical Research (Excluding Clinical Trials)·2019
Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay
OncoImmunology·2015· 74 citedOpen Access
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
Annals of Oncology·2015· 67 citedOpen Access
PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator–dependent autoimmunity
Journal of Allergy and Clinical Immunology·2015· 107 citedOpen Access
Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1st line metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number
Cancer Research·2014
Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome
European Journal of Cancer·2012· 76 cited
Anti-MDR1 siRNA restores chemosensitivity in chemoresistant breast carcinoma and osteosarcoma cell lines.
PubMed·2011· 33 cited
Lung cancer mortality and iron oxide exposure in a French steel-producing factory
Occupational and Environmental Medicine·2008· 30 cited
Epidemiological study in the Arcelor steel plant in Dunkerque
Revue de Métallurgie·2006

Frequent Co-authors

Christophe Caux(7), Christine Ménétrier‐Caux(7), Estelle Verronèse(6), Ana Sofia Delgado(4), Christine Bardin(4), Olivier Trédan(4), Thomas Bachelot(4), C. Bardin-dit-Courageot(4), Gilles Clapisson(3), Sylvie Chabaud(3), Jean‐Yves Blay(3), Isabelle Ray‐Coquard(3), Axelle Nkodia(3), David Pérol(3), Manuarii Manuel(2), Nicolas Pasqual(2), G. Garin(2), Claire Cropet(2), Paul Rebattu(2), Pierre-Étienne Heudel(2)